Sophia, a world-renowned robot, has been the center of attention at an Artificial Intelligence and Innovation fair in Zimbabwe this week

"AI will impact every industry on Earth, from manufacturing and agriculture to healthcare and beyond." Sophia speaks on a Financial Times panel about the future of AI. The EU often provides a ...

UNDP said it hoped Sophia’s engagement would “inspire Zimbabwe’s youth to explore careers in AI and STEM fields.”

UNDP said it hoped Sophia’s engagement would “inspire Zimbabwe’s youth to explore careers in AI and STEM fields.” Mets land Manaea ... Latest on Harborside sale ... Take holiday road to ...

Sophia, a Famous Robot and Global Icon of AI, Wins Hearts at Zimbabwe's Innovation Fair HARARE, Zimbabwe (AP) — From answering questions from Cabinet ministers, academics and students on climate ...

UNDP said it hoped Sophia’s engagement would “inspire Zimbabwe’s youth to explore careers in AI and STEM fields.” Tiger's son comes up aces in PNC Championship with a hole-in...

A recent study conducted by online small business lender OnDeck, ranked Idaho No. 1 in the nation in the arena of small business growth.

OpenAI is reportedly considering building a humanoid robot. The company has also invested in several robotics startups such as Physical Intelligence.

It was a chilly January morning in 2025, and Nita sat by her window, sipping her usual  morning coffee and gazing at the silent cold streets. Life had changed dramatically over the  past two

Sophia, for instance, is celebrated for its human-like conversational abilities and facial expressions, utilizing AI to analyze and respond to language effectively. Atlas excels in complex movements and environmental navigation, leveraging AI to handle ...

Ryze Labs, a leading investor in top-tier Web3 projects, today announced the first cohort of its AI Combinator program, welcoming Eliza, GNON, and Bitte as the inaugural participants. Additionally, two new advisors and four partners were onboarded to provide support to portfolio companies building through the program.

A machine learning tool incorporating both clinical and genomic data helps predict response to CDK4/6 inhibitor therapy in HR+/HER2– advanced breast cancer.